1Dunstan, D, Zimmet, P, Welborn, T, et al. (2002) The rising preverlence of diabetes and impared glucose tolerance: The Australian Diabetes and Lifestlye Study. Diabetes Care 28, 829–834.
2Haffner, SM (1998) Epidemiology of type 2 diabetes: risk factors. Diabetes Care 21, Suppl. 3, C3–C6.
3Marks, JB & Raskin, P (2000) Cardiovascular risk in diabetes: a brief review. J Diabetes Complications 14, 108–115.
4Gannon, M, Nuttall, FQ, Saeed, A, et al. (2003) An increase in dietary protein improves blood glucose response in persons with type 2 diabetes. Am J Clin Nutr 78, 734–741.
5Baba, NH, Sawaya, S, Torbay, N, et al. (1999) High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects. Int J Obes Relat Metab Disord 23, 1202–1206.
6Layman, DK, Boileau, RA, Erickson, DJ, et al. (2003) A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr 133, 411–417.
7Piatti, PM, Monti, F, Fermo, I, et al. (1994) Hypocaloric high-protein diet improves glucose oxidation and spares lean body mass: comparison to hypocaloric high-carbohydrate diet. Metabolism 43, 1481–1487.
8Skov, AR, Toubro, S, Ronn, B, et al. (1999) Randomized trial on protein vs carbohydrate in ad libitum fat reduced diet for the treatment of obesity. Int J Obes Relat Metab Disord 23, 528–536.
9Hu, FB, Stampfer, MJ, Rimm, EB, et al. (1999) A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 281, 1387–1394.
10Tanasescu, M, Cho, E, Manson, JE, et al. (2004) Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr 79, 999–1005.
11Weggemans, RM, Zock, PL & Katan, MB (2001) Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr 73, 885–891.
12Reaven, GM (2001) Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women. Metabolism 50, 594–597.
13Romano, G, Tilly-Kiesi, MK, Patti, L, et al. (1998) Effects of dietary cholesterol on plasma lipoproteins and their subclasses in IDDM patients. Diabetologia 41, 193–200.
14Tannock, LR, O'Brien, KD, Knopp, RH, et al. (2005) Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 111, 3058–3062.
15WHO/Internation Diabetes Federation (2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: WHO/Internation Diabetes Federation.
16World Health Organization (1980) World Health Organization: Expert Committee on Diabetes Mellitus. Report . Geneva: World Health Organization.
17Friedewald, WT, Levy, RI & Fredrickson, DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
18Wallace, TM, Levy, JC & Matthews, DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487–1495.
19Yang, CS & Lee, MJ (1987) Methodology of plasma retinol, tocopherol and carotenoid assays in cancer prevention studies. J Nutr Growth Cancer 4, 1927.
20Khachik, F, Beecher, GR, Goli, MB, et al. (1992) Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 64, 2111–2122.
21Clifton, PM, Noakes, M, Ross, D, et al. (2004) High dietary intake of phytosterol esters decreases carotenoids and increases plasma plant sterol levels with no additional cholesterol lowering. J Lipid Res 45, 1493–1499.
22Baecke, JA, Burema, J & Frijters, JE (1982) A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36, 936–942.
23Parker, B, Noakes, M, Luscombe, N, et al. (2002) Effect of a high-protein, high-monounsaturated fat weight loss diet on glycemic control and lipid levels in type 2 diabetes. Diabetes Care 25, 425–430.
24Boden, WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86, 19L–22L.
25Mutungi, G, Ratliff, J, Puglisi, M, et al. (2008) Dietary cholesterol from eggs increases plasma HDL cholesterol in overweight men consuming a carbohydrate-restricted diet. J Nutr 138, 272–276.
26Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.
27Grundy, SM, Wilhelmsen, L, Rose, G, et al. (1990) Coronary heart disease in high-risk populations: lessons from Finland. Eur Heart J 11, 462–471.
28Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383–1389.
29Spady, DK & Dietschy, JM (1988) Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest 81, 300–309.
30Knopp, RH, Retzlaff, B, Fish, B, et al. (2003) Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterioscler Thromb Vasc Biol 23, 1437–1443.
31Herron, KL, Lofgren, IE, Adiconis, X, et al. (2006) Associations between plasma lipid parameters and APOC3 and APOA4 genotypes in a healthy population are independent of dietary cholesterol intake. Atherosclerosis 184, 113–120.
32Herron, KL, McGrane, MM, Waters, D, et al. (2006) The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr 136, 1161–1165.
33Herron, KL, Vega-Lopez, S, Conde, K, et al. (2002) Pre-menopausal women, classified as hypo- or hyper-responders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J Am Coll Nutr 21, 250–258.
34Austin, MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb Vasc Biol 11, 2–14.
35Verschuren, WM, Jacobs, DR, Bloemberg, BP, et al. (1995) Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274, 131–136.
36Sattar, N, Williams, K, Sniderman, AD, et al. (2004) Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110, 2687–2693.
37Strandberg, TE, Pyorala, K, Cook, TJ, et al. (2004) Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 364, 771–777.
38Sniderman, AD, Furberg, CD & Keech, A (2003) Apoproteins versus lipids as indices of coronary risk and as targets for statin therapy. Lancet 361, 777–780.
39Linn, S, Fulwood, R, Carroll, M, et al. (1991) Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Public Health 81, 1038–1043.
40Castelli, WP (1988) Cholesterol and lipids in the risk of coronary artery disease–the Framingham Heart Study. Can J Cardiol 4, Suppl. A, 5A–10A.
41Bostom, AG, Gagnon, DR, Cupples, LA, et al. (1994) A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study. Circulation 90, 1688–1695.
42Bostom, AG, Cupples, LA, Jenner, JL, et al. (1996) Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 276, 544–548.
43Wing, RR, Koeske, R, Epstein, LH, et al. (1987) Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 147, 1749–1753.
44Ginsberg, H, Plutzky, J & Sobel, BE (1999) A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level lowering. J Cardiovasc Risk 6, 337–346.
45Stamler, J, Vaccaro, O, Neaton, JD, et al. (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16, 434–444.
46Yancy, WS Jr, Foy, M, Chalecki, AM, et al. (2005) A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2, 34.